These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 30445002)

  • 1. Reviewing two decades of nanomedicine implementations in targeted treatment and diagnosis of pancreatic cancer: An emphasis on state of art.
    El-Zahaby SA; Elnaggar YSR; Abdallah OY
    J Control Release; 2019 Jan; 293():21-35. PubMed ID: 30445002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The new era of pancreatic cancer treatment: Application of nanotechnology breaking through bottlenecks.
    Luo W; Zhang T
    Cancer Lett; 2024 Jul; 594():216979. PubMed ID: 38795762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging nanomedicine-based strategies for preventing metastasis of pancreatic cancer.
    Li YJ; Wu JY; Wang JM; Xiang DX
    J Control Release; 2020 Apr; 320():105-111. PubMed ID: 31978441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Theranostic nanoparticles for detection and treatment of pancreatic cancer.
    Agarwal H; Bynum RC; Saleh N; Harris D; MacCuaig WM; Kim V; Sanderson EJ; Dennahy IS; Singh R; Behkam B; Gomez-Gutierrez JG; Jain A; Edil BH; McNally LR
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2024; 16(4):e1983. PubMed ID: 39140128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stromal barriers to nanomedicine penetration in the pancreatic tumor microenvironment.
    Tanaka HY; Kano MR
    Cancer Sci; 2018 Jul; 109(7):2085-2092. PubMed ID: 29737600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanomedicine in Pancreatic Cancer: A New Hope for Treatment.
    Redruello P; Perazzoli G; Cepero A; Quiñonero F; Mesas C; Doello K; Láinez-Ramos-Bossini A; Rivera-Izquierdo M; Melguizo C; Prados J
    Curr Drug Targets; 2020; 21(15):1580-1592. PubMed ID: 32619168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. pH-sensitive nano-systems for drug delivery in cancer therapy.
    Liu J; Huang Y; Kumar A; Tan A; Jin S; Mozhi A; Liang XJ
    Biotechnol Adv; 2014; 32(4):693-710. PubMed ID: 24309541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery.
    Danhier F; Feron O; Préat V
    J Control Release; 2010 Dec; 148(2):135-46. PubMed ID: 20797419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanomedicines Targeting the Tumor Microenvironment.
    Tong R; Langer R
    Cancer J; 2015; 21(4):314-21. PubMed ID: 26222084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of nano engineered approaches to overcome the stromal barrier in pancreatic cancer.
    Meng H; Nel AE
    Adv Drug Deliv Rev; 2018 May; 130():50-57. PubMed ID: 29958925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging inorganic nanomaterials for pancreatic cancer diagnosis and treatment.
    Yang F; Jin C; Subedi S; Lee CL; Wang Q; Jiang Y; Li J; Di Y; Fu D
    Cancer Treat Rev; 2012 Oct; 38(6):566-79. PubMed ID: 22655679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emergence in protein derived nanomedicine as anticancer therapeutics: More than a tour de force.
    Wang Z; Zhi K; Ding Z; Sun Y; Li S; Li M; Pu K; Zou J
    Semin Cancer Biol; 2021 Feb; 69():77-90. PubMed ID: 31962173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging therapeutic nanotechnologies in pancreatic cancer: advances, risks and challenges.
    Rebelo A; Reis C
    Ther Deliv; 2018 Oct; 9(10):691-694. PubMed ID: 30277137
    [No Abstract]   [Full Text] [Related]  

  • 15. The Clinical Translation of Organic Nanomaterials for Cancer Therapy: A Focus on Polymeric Nanoparticles, Micelles, Liposomes and Exosomes.
    Palazzolo S; Bayda S; Hadla M; Caligiuri I; Corona G; Toffoli G; Rizzolio F
    Curr Med Chem; 2018; 25(34):4224-4268. PubMed ID: 28875844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanocarriers for anticancer drugs--new trends in nanomedicine.
    Drbohlavova J; Chomoucka J; Adam V; Ryvolova M; Eckschlager T; Hubalek J; Kizek R
    Curr Drug Metab; 2013 Jun; 14(5):547-64. PubMed ID: 23687925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanotechnological carriers for cancer chemotherapy: the state of the art.
    Estanqueiro M; Amaral MH; Conceição J; Sousa Lobo JM
    Colloids Surf B Biointerfaces; 2015 Feb; 126():631-48. PubMed ID: 25591851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted drug delivery systems for pancreatic cancer.
    Khare V; Alam N; Saneja A; Dubey RD; Gupta PN
    J Biomed Nanotechnol; 2014 Dec; 10(12):3462-82. PubMed ID: 26000366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance.
    Shapira A; Livney YD; Broxterman HJ; Assaraf YG
    Drug Resist Updat; 2011 Jun; 14(3):150-63. PubMed ID: 21330184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanotechnologies for noninvasive measurement of drug release.
    Moore T; Chen H; Morrison R; Wang F; Anker JN; Alexis F
    Mol Pharm; 2014 Jan; 11(1):24-39. PubMed ID: 24215280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.